Senior insider sale
SVP, Finance & Accounting at KURA ONCOLOGY, INC. — senior position signals high conviction
$60.5K
7.14K shares
What this filing means
DOYLE THOMAS JAMES plans to sell 7.14K shares of KURA ONCOLOGY, INC. valued at approximately $60.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/27/2026ACC: 0001193125-26-025291
Officer· SVP, Finance & Accounting
Since Feb 2022
7.14K
Shares to sell
$60.5K
Approx. market value
7.14K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
RSU
N/A
1/27/2026
1.11KRSU
N/A
1/27/2026
881.00RSU
N/A
1/27/2026
695.00RSU
N/A
1/27/2026
2.23KRSU
N/A
1/27/2026
2.23KTotal acquired7.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2026 | RSU N/A | 1.11K | — |
1/27/2026 | RSU N/A | 881.00 | — |
1/27/2026 | RSU N/A | 695.00 | — |
1/27/2026 | RSU N/A | 2.23K | — |
1/27/2026 | RSU N/A | 2.23K | — |
| Total | 7.14K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.14K
Market value
$60.5K
1/27/2026
Total
Units
7.14K
Value
$60.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/27/2026 | 7.14K | $60.5K | NASDAQ | Planned |
| Total | 7.14K | $60.5K | ||